WAM
DGX icon

Wakefield Asset Management’s Quest Diagnostics DGX Stock Holding History

Wakefield Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,251
Closed -$2.87M – 156
2023
Q1 		$2.87M Sell
20,251
-59
-0.3% -$8.44K 1.19% 23
2022
Q4 		$3.18M Sell
20,310
-8
-0% -$1.15K 1.34% 12
2022
Q3 		$2.49M Sell
20,318
-147
-0.7% -$19.4K 1.14% 25
2022
Q2 		$2.72M Buy
+20,465
New +$2.79M 1.17% 18
2022
Q1 		– Sell
-11,112
Closed -$1.92M – 174
2021
Q4 		$1.92M Buy
11,112
+311
+3% +$47.3K 0.66% 52
2021
Q3 		$1.57M Sell
10,801
-118
-1% -$17.3K 0.59% 58
2021
Q2 		$1.44M Sell
10,919
-7,815
-42% -$1.02M 0.55% 63
2021
Q1 		$2.4M Sell
18,734
-995
-5% -$123K 0.96% 33
2020
Q4 		$2.35M Sell
19,729
-1,517
-7% -$185K 0.99% 31
2020
Q3 		$2.43M Sell
21,246
-436
-2% -$51.5K 1.14% 27
2020
Q2 		$2.47M Buy
+21,682
New +$2.3M 1.18% 17

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wakefield Asset Management's DGX Position: Q2 2023 in Review

Wakefield Asset Management sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 20,251 shares — an estimated $2.87M sold.

Wakefield Asset Management first reported a position in DGX in Q2 2020 and held it in 11 quarters. The position peaked at $3.18M in Q4 2022. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • Wakefield Asset Management reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Wakefield Asset Management sold 20,251 Quest Diagnostics shares in Q2 2023, an estimated $2.87M.
  • Wakefield Asset Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 11 quarters.
  • Wakefield Asset Management's Quest Diagnostics position peaked at $3.18M in Q4 2022.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Wakefield Asset Management's 13F filing for Q2 2023, filed 1 Aug 2023.